Antabio's Unattributed Round

Antabio raised a round of funding on April 09, 2015. Investors include BPI France.

Antabio is a biopharmaceutical company developing novel antibacterial resistance-breakers to treat drug-resistant infections in areas of highest unmet medical need.…

Articles about Antabio's Unattributed Round: